Company / Capital Returned to Shareholders per Share
ImmunityBio, Inc. Capital Returned to Shareholders per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.01
FY2021
5-year range
$0.01 / $0.01
FY2017-FY2021
Trend
-
vs FY2020
Sector context
#45 of 51
Health Care
What the data says
ImmunityBio, Inc.'s capital returned to shareholders per share of $0.01 is lower than 88% of companies in the Health Care sector (FY2021). Capital Returned to Shareholders per Share returned to growth in FY2021 after 2 years of decline, reaching $0.01.
Based on SEC 10-K filings.
0.01 in FY2021 with a 3-year CAGR of -68.0%.
Declined from $0.03 to $0.01 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -68.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-99.8% below sector average
Key checks
Key Insights
- Ranks #45 out of 51 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2018.
- Lowest capital returned to shareholders per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.01 | - |
| FY2020 | $0.00 | -100.0% |
| FY2019 | $0.03 | -84.2% |
| FY2018 | $0.20 | +242.7% |
| FY2017 | $0.06 | - |
| FY2016 | $0.00 | -100.0% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026